Fidelity Japan Trust long-term record of outperforming UK markets and Japanese benchmarks (LON:FJV) 17 February 2022
CentralNic Group 2022 revenue and EBITDA forecasts upgraded by Zeus Capital (LON:CNIC) 17 February 2022
Cizzle Biotechnology significantly increased ability to bring money and value to shareholders (LON:CIZ) 17 February 2022
Dekel Agri-Vision strong start to the year with more high season big months to come (LON:DKL) 16 February 2022
Helium One CEO David Minchin discusses additional helium anomalies, share price and horizon (Interview)
Oncimmune “COVID-19 NavigAID panel participation enhances the investment case” says Zeus Capital 7 October 2020
Surface Transforms “well positioned to deliver for the medium-term” says Zeus Capital 29 September 2020
GYG “order book is at record levels providing more forward visibility than ever before” says Zeus Capital 25 September 2020
Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Whitbread Plc remain confident to deliver a step change in profits, margins and returns 16 January 2025
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Challenges with a 25% Potential Upside 19 December 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Report: Navigating the Skies with a 5.21% Potential Upside 19 December 2025
Trustpilot Group PLC (TRST.L): Analyst Consensus Reveals 84% Potential Upside for Investors 19 December 2025
Fidelity Japan Trust long-term record of outperforming UK markets and Japanese benchmarks (LON:FJV) 17 February 2022
CentralNic Group 2022 revenue and EBITDA forecasts upgraded by Zeus Capital (LON:CNIC) 17 February 2022
Cizzle Biotechnology significantly increased ability to bring money and value to shareholders (LON:CIZ) 17 February 2022
Dekel Agri-Vision strong start to the year with more high season big months to come (LON:DKL) 16 February 2022
Helium One CEO David Minchin discusses additional helium anomalies, share price and horizon (Interview)
Oncimmune “COVID-19 NavigAID panel participation enhances the investment case” says Zeus Capital 7 October 2020
Surface Transforms “well positioned to deliver for the medium-term” says Zeus Capital 29 September 2020
GYG “order book is at record levels providing more forward visibility than ever before” says Zeus Capital 25 September 2020
Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Whitbread Plc remain confident to deliver a step change in profits, margins and returns 16 January 2025
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Challenges with a 25% Potential Upside 19 December 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Report: Navigating the Skies with a 5.21% Potential Upside 19 December 2025
Trustpilot Group PLC (TRST.L): Analyst Consensus Reveals 84% Potential Upside for Investors 19 December 2025
Choice Hotels International, Inc. – Consensus ‘none’ rating and -13.5% Downside Potential 3 December 2024
Helium One CEO David Minchin discusses additional helium anomalies, share price and horizon (Interview) 18 January 2022
CyanConnode discuss record results, financial projection and priorities in 2022 (Interview) 18 January 2022
Kenmare Resources CEO: “almost US$100 million shareholder returns in 2021” (Interview) 14 January 2022
ICG Enterprise, Intermediate Capital Group ICGT: friends with benefits (Analyst Interview) 13 January 2022
Fidelity Japan Trust long-term record of outperforming UK markets and Japanese benchmarks (LON:FJV) 17 February 2022
CentralNic Group 2022 revenue and EBITDA forecasts upgraded by Zeus Capital (LON:CNIC) 17 February 2022
Cizzle Biotechnology significantly increased ability to bring money and value to shareholders (LON:CIZ) 17 February 2022
Dekel Agri-Vision strong start to the year with more high season big months to come (LON:DKL) 16 February 2022
Oncimmune “COVID-19 NavigAID panel participation enhances the investment case” says Zeus Capital 7 October 2020
Surface Transforms “well positioned to deliver for the medium-term” says Zeus Capital 29 September 2020
GYG “order book is at record levels providing more forward visibility than ever before” says Zeus Capital 25 September 2020
Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Workspace Group PLC (WKP.L) Stock Analysis: Navigating Challenges with a 25% Potential Upside 19 December 2025
Wizz Air Holdings PLC (WIZZ.L) Stock Report: Navigating the Skies with a 5.21% Potential Upside 19 December 2025
Trustpilot Group PLC (TRST.L): Analyst Consensus Reveals 84% Potential Upside for Investors 19 December 2025
